Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 82 NE 26th St Unit 110 MIAMI FL 33137-4442 |
Tel: | 1-720-3302829 |
Website: | cansortium.com |
IR: | See website |
Key People | ||
William Smith Executive Chairman of the Board | Robert Beasley Chief Executive Officer, Director | Jeffrey Batliner Chief Financial Officer |
Samantha Hymes Executive Vice President | Victor Bindi Sales Director | Todd Buchman Chief Legal Officer and Corporate Secretary |
Business Overview |
Cansortium Inc. is a vertically integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the private label, Fluent. The Company, through its subsidiaries, is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The Company's medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges and edibles and accessories. The Company's subsidiaries include Cansortium Holdings LLC, Cansortium Pennsylvania, LLC, Cansortium Puerto Rico, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Fluent Servicing, LLC, Cansortium Florida, LLC., Spirit Lake Road Nursery, LLC, Harvest Park Lot 9 Investors LLC, Fluent Hemp LLC and Cansortium Michigan LLC. |
Financial Overview |
For the fiscal year ended 31 December 2023, Cansortium Inc revenues increased 11% to $97.3M. Net loss before extraordinary items decreased 39% to $22.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Pharmaceuticals segment income increase from $3.9M to $9.3M. |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $140.24M as of Dec 31, 2023 |
Annual revenue (TTM): | $97.29M as of Dec 31, 2023 |
EBITDA (TTM): | $40.33M as of Dec 31, 2023 |
Net annual income (TTM): | -$25.30M as of Dec 31, 2023 |
Free cash flow (TTM): | $12.12M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $91.00M as of Dec 31, 2023 |
Shares outstanding: | 299,529,367 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |